John C. Brown
Plus aucun poste en cours
Profil
John C.
Brown is the founder of QLT, Inc. (founded in 1981).
Dr. Brown is also the founder of ImmGenics, Inc., enGene, Inc...
Anciens postes connus de John C. Brown
| Sociétés | Poste | Fin |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Fondateur | - |
ImmGenics, Inc.
 ImmGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., ImmGenics, Inc. is a Canadian company that developed a technology which increases both the effectiveness and speed of antibody product discovery efforts. The company is based in Vancouver, Canada. The company was founded by John C. Brown. ImmGenics was acquired by Abgenix, Inc. on November 06, 2000 for $77 million. | Fondateur | - |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
ImmGenics, Inc.
ImmGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., ImmGenics, Inc. is a Canadian company that developed a technology which increases both the effectiveness and speed of antibody product discovery efforts. The company is based in Vancouver, Canada. The company was founded by John C. Brown. ImmGenics was acquired by Abgenix, Inc. on November 06, 2000 for $77 million. | Commercial Services |
